Robin Kobbe

Robin Kobbe is a Clinical Associate Professor in Pediatrics and Youth Medicine at the University of Hamburg's Faculty of Medicine, affiliated with the University Medical Center Hamburg-Eppendorf (UKE). He specializes in immunology and pediatric infectious diseases, with a focus on global health, vaccine development, and the management of immunodeficiencies. His work spans clinical research, epidemiology, and public health, particularly addressing challenges in refugee populations and tropical medicine.

Dr. Kobbe holds an Oxford Postgraduate Diploma in Paediatric Infectious Diseases (with distinction). His research encompasses SARS-CoV-2 immunology, malaria prevention strategies, and the clinical management of immunocompromised patients. He has contributed to multinational studies on pediatric COVID-19 outcomes and post-pandemic syndromes. He is also involved in global health initiatives, such as evaluating infectious disease prevalence among Ukrainian refugees in Germany and optimizing vaccine responses in immunosuppressed children.

His work frequently intersects with clinical trials and observational studies, including investigations into monoclonal antibody therapies, dolutegravir-based antiretroviral treatment in HIV-positive children, and the long-term antibody profiles post-COVID-19 vaccination. His expertise is reflected in leadership roles within professional societies like the European Society for Immunodeficiencies and the Deutsche Gesellschaft für Pädiatrische Infektiologie.

Publications highlight his contributions to understanding SARS-CoV-2 variants, pediatric sepsis microbiomics, and the epidemiology of infectious diseases in resource-limited settings. He actively collaborates with international networks such as the ISARIC (International Severe Acute Respiratory and Emerging Infection Consortium) to improve pandemic response through open clinical data sharing.